Page last updated: 2024-12-07

nitrofenac

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

nitrofenac: a diclofenac-derivative containing the nitric oxide group; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID132976
SCHEMBL ID3332430
MeSH IDM0231985

Synonyms (14)

Synonym
nitrofenac
4-nitrooxybutyl 2-[2-(2,6-dichloroanilino)phenyl]acetate
nz947h5r0j ,
unii-nz947h5r0j
156661-01-7
4-(nitrooxy)butyl 2-((2,6-dichlorophenyl)amino)benzeneacetate
benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, 4-(nitrooxy)butyl ester
SCHEMBL3332430
2-((2,6-dichlorophenyl) amino)benzeneacetate-4-hydroxybutylnitric ester
benzeneacetic acid,2-((2,6-dichlorophenyl)amino)-, 4-(nitrooxy)butyl ester
154766-10-6
DTXSID20935062
4-(nitrooxy)butyl [2-(2,6-dichloroanilino)phenyl]acetate
Q27285119

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" This method has been applied to evaluate the pharmacokinetic parameters of the drugs, using a noncompartmental model, after the oral administration of 5 mg/kg nitrofenac to rats."( Plasma concentrations and pharmacokinetic parameters of nitrofenac using a simple and sensitive HPLC method.
Adami, A; Benoni, G; Cuzzolin, L; Del Soldato, P; Grigolini, L; Terzi, M, 1995
)
0.73
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.25 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]